Article Details

Single-dose lysin shows promise against S. aureus in phase 2 trial - Healio

Retrieved on: 2021-10-02 19:41:15

Tags for this article:

Click the tags to see associated articles and topics

Single-dose lysin shows promise against S. aureus in phase 2 trial - Healio. View article details on hiswai:

Excerpt

... and development at ContraFect Corporation — the biotechnology company that created exebacase — and colleagues conducted a randomized, double-blind, ...

Article found on: www.healio.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up